<DOC>
	<DOCNO>NCT01408069</DOCNO>
	<brief_summary>The purpose study evaluate non-inferiority clinical efficacy two different association drug treatment patient diagnose tensional-type headache accordance International Headache Society guideline .</brief_summary>
	<brief_title>Non-Inferiority Comparison Migrane® Versus Parcel ® For Treatment Tensional Cephaleia</brief_title>
	<detailed_description>- Open-label , non-inferiority , prospective , parallel group , intent treat trial . - Experiment duration : 56 day . - 04 visit ( day -7 , 0 , 28 56 ) . - Efficacy evaluate 10 episode tension-type headache . - Adverse event evaluation .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Ergotamine</mesh_term>
	<criteria>1 . Patients must able understand study procedure agree participate give write consent . 2 . Tensionaltype headache patient accord International Headache Society criterion . 3 . Corporal body index &lt; 40 . 1 . Pregnancy risk pregnancy . 2 . Lactation 3 . Use acetylsalicylic acid corticosteroid immunosuppressive therapy . 4 . Use immunosuppressive drug . 5 . Alterations laboratory selective test . 6 . Drugs alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>headache</keyword>
	<keyword>migraine</keyword>
</DOC>